<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28938" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Severe Combined Immunodeficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Justiz Vaillant</surname>
            <given-names>Angel A.</given-names>
          </name>
          <aff>University of the West Indies</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mohseni</surname>
            <given-names>Michael</given-names>
          </name>
          <aff>Mayo Clinic</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Angel Justiz Vaillant declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Mohseni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28938.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Severe combined immunodeficiency disease (SCID) is an inherited primary immunodeficiency disorder that presents by six months of age with opportunistic infections caused by bacteria, viruses, fungi, and protozoa. It is one of the most serious primary immunodeficiency disorders with early death due to disturbed or absent T and B cell functions. This activity outlines the evaluation and management of severe combined immunodeficiency disease and highlights the role of the interprofessional team in improving outcomes for those with the disease.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of severe combined immunodeficiency disease.</p></list-item><list-item><p>Outline the history and physical exam of a patient with severe combined immunodeficiency disease.</p></list-item><list-item><p>Summarize the treatment options for severe combined immunodeficiency disease.</p></list-item><list-item><p>Identify the importance of improving care coordination among the interprofessional team in counseling the parents of those with severe combined immunodeficiency disease.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28938&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28938">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28938.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Patients with combined immunodeficiency disorder (T and B lymphocyte deficiency) present&#x000a0;with recurrent infections usually early in life. These patients are susceptible to infection by many organisms. Immunotherapy sometimes is not available to treat these recurrent infections. Severe combined immunodeficiency disease (SCID) is the most severe expression among the combined immunodeficiency disorders. The onset of the clinical manifestations occurs by 6 months of age or before, with bacterial, viral, fungal and protozoal infections. Also, these infections may lead to early death in severe combined immunodeficiency disease, differentiating this condition from other forms or combined immunodeficiency.&#x000a0;</p>
        <p>Both T and B cell functions are disturbed or absent entirely in severe combined immunodeficiency disease. Autosomal, sporadic, or the X-linked form may affect the neonate, and without treatment, patients rarely survive beyond one year of age before&#x000a0;succumbing to&#x000a0;opportunistic infections.<xref ref-type="bibr" rid="article-28938.r1">[1]</xref><xref ref-type="bibr" rid="article-28938.r2">[2]</xref><xref ref-type="bibr" rid="article-28938.r3">[3]</xref></p>
      </sec>
      <sec id="article-28938.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Some causes and examples of SCID<xref ref-type="bibr" rid="article-28938.r4">[4]</xref><xref ref-type="bibr" rid="article-28938.r5">[5]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p>T-B-NK- SCID can be seen in reticular dysgenesis caused by a lack of stem cells. A similar phenotype (T-B-NK-) occurs in adenosine deaminase (ADA) deficiency, and defective ADA genes cause it leads to toxic metabolites in T, B, and NK cells.&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>T-B-NK+ SCID (RAG1/2 defect) can cause SCID due to RAG1/2 enzymes to snip DNA for VDJ rearrangement for TCR and BCR. A similar phenotype is Artemis deficiency characterized by a failure to repair DNA after RAG1/2 snips.&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>T-B+NK- SCID can be X linked and due to absent IL receptor for a range of cytokines due to lack of common gamma chain. A similar phenotype named Jak 3 kinase deficiency is caused by a lack of Jak 3 kinase to follow signal via IL-R binding.&#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>T-B+NK+ SCID is the phenotype of IL-7 deficiency when there are no IL-7 alpha chains that lead to the failure of T cell differentiation. A similar phenotype is present in CD3 activation failure, characterized by defective signal transduction, e.g., ZAP-70 deficiency.&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>T+B+NK+ MHC failure is a phenotype that has two conditions: MHC class I deficiency (bare lymphocyte syndrome) and MHC class II deficiency. The first condition is caused by failure to express MHC class I caused by a defect in TAP-2 transcription. The second condition is due to a defect in transcription of MHC class II proteins.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28938.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The Jeffrey Modell Foundation implemented public awareness and physician education about primary immunodeficiencies, including severe combined immunodeficiency disease beginning in 2003. The network has implemented population-based newborn screening for SCID and T cell lymphopenia, covering 96% of the total newborns in the US.<xref ref-type="bibr" rid="article-28938.r6">[6]</xref></p>
        <p>The majority of the patients (89%) presented with the first symptoms within six months of age. The clinical manifestations observed were recurrent pneumonia (66%), followed by failure to thrive (60%) and chronic diarrhea (35%).<xref ref-type="bibr" rid="article-28938.r1">[1]</xref></p>
        <p>One US study reported the incidence of SCID as 1 in 58,000 live births.<xref ref-type="bibr" rid="article-28938.r7">[7]</xref>&#x000a0; Consanguineous relationships have been shown to have a&#x000a0;higher incidence of autosomal-recessive SCID.<xref ref-type="bibr" rid="article-28938.r8">[8]</xref></p>
      </sec>
      <sec id="article-28938.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Genetic mutation is the root cause of SCID.&#x000a0; Specifically, the genes which are responsible for the function of T and B cells are affected in SCID.&#x000a0; Profound T-cell abnormalities can prevent B cells from functioning normally because the B cells require signals from T cells to produce appropriate antibodies.&#x000a0; Therefore, in some instances, SCID may be present with only T cell dysfunction.&#x000a0; Natural killer (NK) cells develop separately from T and B cells and can provide a degree of protection in individuals with T and B cell dysfunction.&#x000a0; Assessing for the presence of NK cells helps determine the severity and prognosis of the SCID.</p>
      </sec>
      <sec id="article-28938.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>In SCID, microscopic examination of the thymic stroma&#x000a0;reveals an absence of lymphoid cells, as well as the absence of Hassall's corpuscles.&#x000a0; In essence, the thymus gland has a fetal appearance.</p>
        <p>Additionally, numerable&#x000a0;<italic toggle="yes">Giardia lamblia</italic>&#x000a0;can present in the gastrointestinal tract, specifically over the mucosa of the jejunum. The lack of protective immunity results in an inability to fight against these intestinal parasites.<xref ref-type="bibr" rid="article-28938.r9">[9]</xref></p>
        <p>Biopsy of lymph nodes (if detectable) shows severe depletion, without cortico-medullary differentiation or follicle formation. Biopsy of the intestinal tract may demonstrate a complete absence of plasma cells.</p>
      </sec>
      <sec id="article-28938.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Major immunological features of severe combined immune deficiency include the following<xref ref-type="bibr" rid="article-28938.r9">[9]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Present in the first few weeks or months of life&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Primarily viral or fungal infections although bacterial and protozoal infections do occur&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Frequent respiratory infections&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Oral candidiasis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Failure to thrive&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Lymphopenia (often overlooked)&#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Infections by rare microorganisms&#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Opportunistic infections&#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Recurrent infections&#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Frequent use of antimicrobials without noticeable improvement&#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Infection and inflammation of internal organs&#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Blood disorders, such as anemia and low platelet count</p>
          </list-item>
          <list-item>
            <p>Autoimmunity may occur</p>
          </list-item>
        </list>
        <p>Physical findings include the following<xref ref-type="bibr" rid="article-28938.r1">[1]</xref><xref ref-type="bibr" rid="article-28938.r4">[4]</xref>]<xref ref-type="bibr" rid="article-28938.r2">[2]</xref><xref ref-type="bibr" rid="article-28938.r10">[10]</xref><xref ref-type="bibr" rid="article-28938.r11">[11]</xref>:&#x000a0;&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Meningitis symptoms&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Septicemia&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Arthritis&#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Bacteremia&#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Fever&#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Frequent cough&#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Malaise&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Intestinal malabsorption&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Bronchiectasis&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Graft versus host reaction&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Recurrent tonsillitis&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Acute suffocation&#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Extensive cutaneous viral and bacterial (Staphylococcal) infections&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Multiple gross defects&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Absence of tonsil&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Sore throat&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Purulent conjunctivitis&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Granuloma&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Skin abnormalities, e.g., pyodermatitis&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Multiple cancers, e.g., brain tumor&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Eczema&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Failure to thrive&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Chronic diarrhea&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Tuberculosis&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Short Stature&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Lymphoproliferative disorders&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The absence of lymph nodes&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Bleeding&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Thymic aplasia or hypoplasia&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Recurrent abscess&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Tetany&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cachexia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Candidiasis (oral and elsewhere)</p>
          </list-item>
          <list-item>
            <p>Lupus-like syndrome</p>
          </list-item>
          <list-item>
            <p>Angioedema</p>
          </list-item>
          <list-item>
            <p>Malnutrition</p>
          </list-item>
          <list-item>
            <p>Cardiac abnormalities, e.g., cardiac murmur and conotruncal malformation&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hypothermia&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Asthenia</p>
          </list-item>
          <list-item>
            <p>Anorexia</p>
          </list-item>
          <list-item>
            <p>Loss of weight</p>
          </list-item>
          <list-item>
            <p>Headache&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Convulsions&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hypoparathyroidism&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Aphthous stomatitis&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Urinary sepsis&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Fetal demise&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hydrops fetalis&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Denture abnormalities&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pruritus&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Vasculitis&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hearing impairment and deafness&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Erythroderma&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Myopathy&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Intrauterine growth retardation&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Dwarfism&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Lymphocytic interstitial pneumonitis&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Albinism&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Microcephaly&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Glomerulonephritis&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hemolytic-uremic syndrome&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Macroglossia&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cafe-au-lait spots&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Exocrine pancreatic insufficiency&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Serositis&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Osteoporosis and fractures&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Scoliosis&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Poor wound healing</p>
          </list-item>
          <list-item>
            <p>Mental retardation&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Nail dystrophy&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Late-onset primary encephalopathy&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Thyroiditis</p>
          </list-item>
          <list-item>
            <p>Urogenital abnormalities&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Venous telangiectasias of trunk and limbs&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Chondrodysplasia</p>
          </list-item>
          <list-item>
            <p>Amyloidosis&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Delayed cord separation&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Periodontitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28938.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The immunological investigation of a patient with SCID includes the assessment of immunoglobulins, including isohemagglutinins and antibody activity, B and T-lymphocyte counts, lymphocyte stimulation assays, NK cell function, quantification of components of the complement system and phagocytic activity.<xref ref-type="bibr" rid="article-28938.r9">[9]</xref><xref ref-type="bibr" rid="article-28938.r12">[12]</xref><xref ref-type="bibr" rid="article-28938.r13">[13]</xref></p>
        <p>
<bold>Blood lymphocyte subpopulations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Total lymphocyte count</p>
          </list-item>
          <list-item>
            <p>T lymphocytes (CD3, CD4, and CD8)</p>
          </list-item>
          <list-item>
            <p>B lymphocytes (CD19 and CD20)</p>
          </list-item>
          <list-item>
            <p>CD4/CD8 ratio</p>
          </list-item>
          <list-item>
            <p>NK cell count</p>
          </list-item>
        </list>
        <p>
<bold>Lymphocyte stimulation assays</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Phorbol ester and ionophore</p>
          </list-item>
          <list-item>
            <p>Phytohemagglutinin</p>
          </list-item>
          <list-item>
            <p>Antiserum to CD3</p>
          </list-item>
        </list>
        <p>
<bold>Quantitative Serum Immunoglobulins</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>IgG</p>
          </list-item>
          <list-item>
            <p>IgM</p>
          </list-item>
          <list-item>
            <p>IgA</p>
          </list-item>
          <list-item>
            <p>IgE</p>
          </list-item>
        </list>
        <p>
<bold>IgG Sub-Classes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>IgG1</p>
          </list-item>
          <list-item>
            <p>IgG2</p>
          </list-item>
          <list-item>
            <p>IgG3</p>
          </list-item>
          <list-item>
            <p>IgG4</p>
          </list-item>
        </list>
        <p>
<bold>Antibody Activity&#x000a0;</bold>
</p>
        <p>
<italic toggle="yes">IgG antibodies (post-immunization)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tetanus toxoid</p>
          </list-item>
          <list-item>
            <p>Diphtheria toxoid</p>
          </list-item>
          <list-item>
            <p>Pneumococcal polysaccharide</p>
          </list-item>
          <list-item>
            <p>Polio</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">IgG antibodies (post-exposure)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Rubella</p>
          </list-item>
          <list-item>
            <p>Measles</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Varicella zoster</italic>
</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Detection of isohemagglutinins (IgM)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Anti-type A blood</p>
          </list-item>
          <list-item>
            <p>Anti-type B blood</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Other assays</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Test for&#x000a0;heterophile antibody</p>
          </list-item>
          <list-item>
            <p>Anti-streptolysin O titer</p>
          </list-item>
          <list-item>
            <p>Immunodiagnosis of infectious diseases (HIV, hepatitis B, and C, HTLV and dengue)</p>
          </list-item>
          <list-item>
            <p>Serum protein electrophoresis</p>
          </list-item>
        </list>
        <p><bold>Phagocytic function</bold>&#x000a0;&#x000a0;</p>
        <p>
<italic toggle="yes">Nitroblue tetrazolium (NBT) test (before and after stimulation with endotoxin)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Unstimulated</p>
          </list-item>
          <list-item>
            <p>Stimulated</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Neutrophil mobility</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>In medium alone</p>
          </list-item>
          <list-item>
            <p>In the presence of chemoattractant</p>
          </list-item>
        </list>
        <p>
<bold>Complement System Evaluation<xref ref-type="bibr" rid="article-28938.r14">[14]</xref></bold>
</p>
        <p>
<italic toggle="yes">Measurement of individuals components by immunoprecipitation tests, ELISA, or Western blotting</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>C3 serum levels</p>
          </list-item>
          <list-item>
            <p>C4 serum levels</p>
          </list-item>
          <list-item>
            <p>Factor B serum levels&#x000a0;</p>
          </list-item>
          <list-item>
            <p>C1 inhibitor serum levels</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Hemolytic assays</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>CH50</p>
          </list-item>
          <list-item>
            <p>CH100</p>
          </list-item>
          <list-item>
            <p>AH50</p>
          </list-item>
        </list>
        <p>
<bold>Microbiological studies</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Blood (bacterial culture, HIV by PCR, HTLV testing)</p>
          </list-item>
          <list-item>
            <p>Urine (testing for cytomegalovirus, sepsis, and proteinuria)</p>
          </list-item>
          <list-item>
            <p>Nasopharyngeal swab (testing for Rhinovirus)</p>
          </list-item>
          <list-item>
            <p>Stool (testing for viral, bacterial or parasitic infection)</p>
          </list-item>
          <list-item>
            <p>Sputum (bacterial culture and pneumocystis PCR)</p>
          </list-item>
          <list-item>
            <p>Cerebrospinal fluid (culture, chemistry, and histopathology)</p>
          </list-item>
        </list>
        <p>
<bold>Autoimmune Studies<xref ref-type="bibr" rid="article-28938.r15">[15]</xref><xref ref-type="bibr" rid="article-28938.r16">[16]</xref></bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Anti-nuclear antibodies (ANA)</p>
          </list-item>
          <list-item>
            <p>Detection of specific auto-immune antibodies for systemic disorders (anti-ds DNA, rheumatoid factor, anti-histones, anti-Smith, anti-(SS-A) and anti-(SS-B)</p>
          </list-item>
          <list-item>
            <p>Detection of anti-RBC, antiplatelet, and anti-neutrophil</p>
          </list-item>
          <list-item>
            <p>Testing for organ-specific auto-immune antibodies</p>
          </list-item>
        </list>
        <p>
<bold>Coagulation tests&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Factor V assay</p>
          </list-item>
          <list-item>
            <p>Fibrinogen level</p>
          </list-item>
          <list-item>
            <p>Prothrombin time</p>
          </list-item>
          <list-item>
            <p>Thrombin time</p>
          </list-item>
          <list-item>
            <p>Bleeding time</p>
          </list-item>
        </list>
        <p><bold>Other investigations of immunodeficiency disorders</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Bone marrow biopsy</p>
          </list-item>
          <list-item>
            <p>Levels of cytokines</p>
          </list-item>
          <list-item>
            <p>Chest x-ray</p>
          </list-item>
          <list-item>
            <p>Diagnostic&#x000a0;ultrasound</p>
          </list-item>
          <list-item>
            <p>CT scan</p>
          </list-item>
          <list-item>
            <p>Histopathological studies</p>
          </list-item>
          <list-item>
            <p>Liver function test</p>
          </list-item>
          <list-item>
            <p>Blood chemistry</p>
          </list-item>
          <list-item>
            <p>Tumoral markers</p>
          </list-item>
          <list-item>
            <p>Complete blood cell count &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Tuberculin test</p>
          </list-item>
          <list-item>
            <p>Fluorescent in situ hybridization (FISH)</p>
          </list-item>
          <list-item>
            <p>DNA testing (for most congenital disorders)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28938.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>A bone marrow transplant may be beneficial in the following sub-groups<xref ref-type="bibr" rid="article-28938.r17">[17]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>RAG1/2 SCID</p>
          </list-item>
          <list-item>
            <p>ADA-SCID&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Artemis SCID</p>
          </list-item>
          <list-item>
            <p>Wiskott-Aldrich syndrome</p>
          </list-item>
        </list>
        <p>Use of gammaglobulin may show benefit in the following sub-groups:</p>
        <list list-type="bullet">
          <list-item>
            <p>ADA-SCID</p>
          </list-item>
          <list-item>
            <p>RAG1/2 SCID</p>
          </list-item>
          <list-item>
            <p>Jak 3 kinase deficiency</p>
          </list-item>
          <list-item>
            <p>Artemis SCID</p>
          </list-item>
          <list-item>
            <p>Bare lymphocyte syndrome</p>
          </list-item>
          <list-item>
            <p>MHC class II deficiency</p>
          </list-item>
          <list-item>
            <p>X-linked SCID</p>
          </list-item>
          <list-item>
            <p>CD3 SCID</p>
          </list-item>
        </list>
        <p>Other treatment options include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Transfer factor</p>
          </list-item>
          <list-item>
            <p>Antibiotics</p>
          </list-item>
          <list-item>
            <p>Antifungals</p>
          </list-item>
          <list-item>
            <p>Antiparasitic drugs</p>
          </list-item>
          <list-item>
            <p>Anti-virals</p>
          </list-item>
          <list-item>
            <p>Irradiated blood transfusions</p>
          </list-item>
          <list-item>
            <p>Vitamins</p>
          </list-item>
          <list-item>
            <p>Gene therapy (experimental)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Anti-inflammatory drugs</p>
          </list-item>
          <list-item>
            <p>Use of cytokines (e.g., IL-2 and gamma interferon)&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28938.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>At the top of the differential for SCID are other forms of combined immunodeficiency.&#x000a0; These patients have several characteristics that overlap in their clinical presentation.&#x000a0; Patients with agenesis of the thymus or T cell deficiency (such as in DiGeorge syndrome or CHARGE syndrome) may present with opportunistic infections similar to SCID.</p>
        <p>&#x000a0;Additional immunodeficiencies that merit consideration in the differential include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Calcium channel deficiencies</p>
          </list-item>
          <list-item>
            <p>Wiskott-Aldrich syndrome</p>
          </list-item>
          <list-item>
            <p>NF-kappa-B essential modifier (NEMO) deficiency</p>
          </list-item>
          <list-item>
            <p>Zeta-chain-associated protein 70 deficiency</p>
          </list-item>
          <list-item>
            <p>HIV/AIDS</p>
          </list-item>
        </list>
        <p>&#x000a0;Malabsorption syndromes that cause extreme malnutrition may also have similar presentations to SCID.<xref ref-type="bibr" rid="article-28938.r18">[18]</xref></p>
      </sec>
      <sec id="article-28938.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>SCID has the poorest prognosis among combined immunodeficiencies unless bone marrow transplantation or gene therapy (experimental) is successfully performed. In general, for improving the quality of life of patients with primary immunodeficiencies, long-term management with antimicrobials is needed. Most primary immunodeficiencies require personalized management, e.g., genetic testing for various enzyme impairments.<xref ref-type="bibr" rid="article-28938.r9">[9]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-28938.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Life-threatening overwhelming infections caused by bacteria, viruses, fungi, and parasites<xref ref-type="bibr" rid="article-28938.r1">[1]</xref><xref ref-type="bibr" rid="article-28938.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Multiorgan failure</p>
          </list-item>
          <list-item>
            <p>Endocrinopathy</p>
          </list-item>
          <list-item>
            <p>Opportunistic malignancy<xref ref-type="bibr" rid="article-28938.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p>Septic shock</p>
          </list-item>
          <list-item>
            <p>Congenital disabilities</p>
          </list-item>
          <list-item>
            <p>Respiratory insufficiency</p>
          </list-item>
          <list-item>
            <p>Anaphylactic shock</p>
          </list-item>
          <list-item>
            <p>Bleeding disorders&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cardiac failure&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Acute and chronic renal failure&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Premature death</p>
          </list-item>
          <list-item>
            <p>Metabolic disturbances (e.g., acidosis and alkalosis)</p>
          </list-item>
          <list-item>
            <p>Neurological complications including seizures and coma</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28938.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>SCID is the most severe expression of all combined immunodeficiencies</p>
          </list-item>
          <list-item>
            <p>NK cells may or may not be present, and establishing the presence or absence of these cells can be helpful in prognostication</p>
          </list-item>
          <list-item>
            <p>Treatment is limited, and the disease is invariably fatal within the first year of life</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28938.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>SCID should be managed by an interprofessional team that likely includes a pediatrician, geneticist, clinical immunologist, pediatrician, nurse practitioner, and an infectious disease specialist. The treatment team may also provide counseling to the parents, given the poor prognosis associated with the disease. Because of the high morbidity of the disorder, a palliative team consisting of a nurse, a social worker, and a pain specialist should also have involvement in the care. Pediatric hematology nurses assist in the care of these patients and report changes to the team. Pharmacists review medications, check for interactions and educate patient's families about side effects and compliance. [Level 5]</p>
      </sec>
      <sec id="article-28938.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28938&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28938">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/severe-combined-immunodeficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28938">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28938/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28938">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28938.s16">
        <title>References</title>
        <ref id="article-28938.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aluri</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dalvi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Terance</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rosenzweig</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Stoddard</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Niemela</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tamankar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mhatre</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bargir</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kulkarni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lashkari</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Krishna</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Govindaraj</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Madkaikar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India.</article-title>
            <source>Front Immunol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>23</fpage>
            <pub-id pub-id-type="pmid">30778343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wekell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hertting</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Holmgren</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fasth</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Fifteen-minute consultation: Recognising primary immune deficiencies in children.</article-title>
            <source>Arch Dis Child Educ Pract Ed</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>104</volume>
            <issue>5</issue>
            <fpage>235</fpage>
            <page-range>235-243</page-range>
            <pub-id pub-id-type="pmid">30733240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies</collab>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Geha</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Casanova</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Conley</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Etzioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hammartr&#x000f6;m</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nonoyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ochs</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Puck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roifman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Seger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wedgwood</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Primary immunodeficiencies: 2009 update.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>124</volume>
            <issue>6</issue>
            <fpage>1161</fpage>
            <page-range>1161-78</page-range>
            <pub-id pub-id-type="pmid">20004777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gennery</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in understanding RAG deficiencies.</article-title>
            <source>F1000Res</source>
            <year>2019</year>
            <volume>8</volume>
            <pub-id pub-id-type="pmid">30800289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flinn</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Gennery</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Adenosine deaminase deficiency: a review.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2018</year>
            <month>Apr</month>
            <day>24</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <pub-id pub-id-type="pmid">29690908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Modell</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Orange</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Modell</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.</article-title>
            <source>Immunol Res</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>736</fpage>
            <page-range>736-53</page-range>
            <pub-id pub-id-type="pmid">26802037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Currier</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brower</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Andruszewski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Abbott</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ballow</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bartoshesky</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Bonilla</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Brokopp</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Caggana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Celestin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Comeau</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Connelly</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Cowan</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dasu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dave</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>De La Morena</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Duffner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Fong</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Forbes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Freedenberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gelfand</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Hale</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hanson</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Hay</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Infante</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kohn</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lorey</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abdel-Mageed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manning</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McGhee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Naides</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Orange</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Porteus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Romberg</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Routes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ruehle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rubenstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saavedra-Matiz</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Secord</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Seroogy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shearer</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Silvers</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Stiehm</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Sugerman</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Tanksley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tierce</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Verbsky</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vogel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Walkovich</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Wasserman</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yates</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Puck</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bonagura</surname>
                <given-names>VR</given-names>
              </name>
            </person-group>
            <article-title>Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.</article-title>
            <source>JAMA</source>
            <year>2014</year>
            <month>Aug</month>
            <day>20</day>
            <volume>312</volume>
            <issue>7</issue>
            <fpage>729</fpage>
            <page-range>729-38</page-range>
            <pub-id pub-id-type="pmid">25138334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Herz</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Al-Mousa</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Combined immunodeficiency: the Middle East experience.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>131</volume>
            <issue>3</issue>
            <fpage>658</fpage>
            <page-range>658-60</page-range>
            <pub-id pub-id-type="pmid">23321211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chinn</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Shearer</surname>
                <given-names>WT</given-names>
              </name>
            </person-group>
            <article-title>Severe Combined Immunodeficiency Disorders.</article-title>
            <source>Immunol Allergy Clin North Am</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>671</fpage>
            <page-range>671-94</page-range>
            <pub-id pub-id-type="pmid">26454313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Staines Boone</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Chinn</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Alaez-Vers&#x000f3;n</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yamazaki-Nakashimada</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Carrillo-S&#x000e1;nchez</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Cruz</surname>
                <given-names>MLH</given-names>
              </name>
              <name>
                <surname>Poli</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez Serrano</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Medina Torres</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Muzquiz Zerme&#x000f1;o</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Forbes</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Espinosa-Rosales</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Espinosa-Padilla</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Orange</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lugo Reyes</surname>
                <given-names>SO</given-names>
              </name>
            </person-group>
            <article-title>Failing to Make Ends Meet: The Broad Clinical Spectrum of DNA Ligase IV Deficiency. Case Series and Review of the Literature.</article-title>
            <source>Front Pediatr</source>
            <year>2018</year>
            <volume>6</volume>
            <fpage>426</fpage>
            <pub-id pub-id-type="pmid">30719430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amatuni</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Currier</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bishop</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Grimbacher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Agarwal-Hashmi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aznar</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Butte</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cowan</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Dorsey</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Dvorak</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kohn</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Markert</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Naides</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sciortino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feuchtbaum</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Koupaei</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Puck</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017.</article-title>
            <source>Pediatrics</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>143</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">30683812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murata</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ram&#x000ed;rez</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Ram&#x000ed;rez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cruz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morales</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Lugo-Reyes</surname>
                <given-names>SO</given-names>
              </name>
            </person-group>
            <article-title>[Discriminant analysis to predict the clinical diagnosis of primary immunodeficiencies: a preliminary report].</article-title>
            <source>Rev Alerg Mex</source>
            <year>2015</year>
            <season>Apr-Jun</season>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>125</fpage>
            <page-range>125-33</page-range>
            <pub-id pub-id-type="pmid">25958376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Routes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abinun</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Al-Herz</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bustamante</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Condino-Neto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De La Morena</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Etzioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gambineri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Haddad</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kobrynski</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Le Deist</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nonoyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Picard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rezaei</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sleasman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Torgerson</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>ICON: the early diagnosis of congenital immunodeficiencies.</article-title>
            <source>J Clin Immunol</source>
            <year>2014</year>
            <month>May</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>398</fpage>
            <page-range>398-424</page-range>
            <pub-id pub-id-type="pmid">24619621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirschfink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mollnes</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>Modern complement analysis.</article-title>
            <source>Clin Diagn Lab Immunol</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>982</fpage>
            <page-range>982-9</page-range>
            <pub-id pub-id-type="pmid">14607856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dosanjh</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Autoimmunity and Immunodeficiency.</article-title>
            <source>Pediatr Rev</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>36</volume>
            <issue>11</issue>
            <fpage>489</fpage>
            <page-range>489-94; quiz 495</page-range>
            <pub-id pub-id-type="pmid">26527628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Rose</surname>
                <given-names>DU</given-names>
              </name>
              <name>
                <surname>Giliani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Lougaris</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lanfranchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moratto</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Martire</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Specchia</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tommasini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Badolato</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Long term outcome of eight patients with type 1 Leukocyte Adhesion Deficiency (LAD-1): Not only infections, but high risk of autoimmune complications.</article-title>
            <source>Clin Immunol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>191</volume>
            <fpage>75</fpage>
            <page-range>75-80</page-range>
            <pub-id pub-id-type="pmid">29548898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shamriz</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Chandrakasan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Update on Advances in Hematopoietic Cell Transplantation for Primary Immunodeficiency Disorders.</article-title>
            <source>Immunol Allergy Clin North Am</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>113</fpage>
            <page-range>113-128</page-range>
            <pub-id pub-id-type="pmid">30466768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borzutzky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Crompton</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bergmann</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Giliani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baxi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neufeld</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <article-title>Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter.</article-title>
            <source>Clin Immunol</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>133</volume>
            <issue>3</issue>
            <fpage>287</fpage>
            <page-range>287-94</page-range>
            <pub-id pub-id-type="pmid">19740703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28938.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanaka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tachibana</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Suda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Noguchi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A severe combined immunodeficiency disease mouse model of human adenocarcinoma with lepidic-predominant growth.</article-title>
            <source>Pathol Res Pract</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>214</volume>
            <issue>12</issue>
            <fpage>2000</fpage>
            <page-range>2000-2003</page-range>
            <pub-id pub-id-type="pmid">30287185</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
